Symrise AG · XETR:SY1
Symrise — H1 2007 Earnings Presentation
14 slides from Symrise's earnings presentation, Aug 9, 2007

Slide 1: Presentation H1 / 2007
Presentation H1 / 2007 August 9, 2007 1

Slide 2: H1 / 07: We Deliver
H1 / 07: WE DELIVER Fx adjusted sales growth in H1 / 07 at 6.8% (4.5% actual) EBITDA margin increased by 2.3 ppt from 19.5% to 21.8% Innovation awards for two Scent & Care “AND” products, strategic partnerships CUTECH and Brain/Analyticon start working Steng and Flavours Direct acquisitions qualifie

Slide 3: We have worked on the AND portfolio in H1 / 07
WE HAVE WORKED ON THE „AND“ PORTFOLIO IN H1 / 07 > STENG acquisition adds to our strength in fast growing “convenience” segment and follows the trend to natural ingredients > Strategic partnership to develop innovative cosmetic products was signed (Cutech) > Beginning of April saw the beginning of t

Slide 4: Core list positions drive growth with multinationals
CORE LIST POSITIONS DRIVE GROWTH WITH MULTINATIONALS > Greater than proportional growth in S&C with big clients (+ 12%) > Proportional growth in F&N, stronger performance held up by slower than expected commercialization from North American customers > We experience increased briefing activities fro

Slide 5: Emerging markets now account for close to 40% of sales
EMERGING MARKETS NOW ACCOUNT FOR CLOSE TO 40% OF SALES Sales split H1 / 07 > Relative weight of Emerging Countries increases and strategy works > Double digit growth in Emerging Markets vs. underlying growth of 6.8% for the Group > Strongest growth in Africa (>+ 15%), South America grows at 14% in H

Slide 6: News
NEWS > Examples of prestigious Fine Fragrances wins: Lancome „Hypnose Homme“, Guerlain „L‘instant magic“, Victoria‘s Secret „Blossoming Romance“, Donna Karan „Be delicious“ line extensions > Star perfumer Jean-Claude Delville hired from top competitor for NY studio > Opening of regional sensory cons

Slide 7: Financials
”) _ < O zZ < Z LL.

Slide 8: H1 / 07 – EBITDA margin improved to 21.8%
H1 / 07 – EBITDA MARGIN IMPROVED TO 21.8% 4.5% 400 300 > Fx adjusted growth of 6.8% (€m) Sales 200 632.3 660.9 > Growth rate (fx adjusted): 100 • F&N 6.1% 0 • S&C 7.5% H1 / 06 H1 / 07 16.4% 80 > EBITDA + € 20.3m yoy 60 EBITDA 1 > EBITDA grows even stronger than top (€m) 40 123.5 143.8 line at 16.4%

Slide 9: H1 / 07 – Balance sheet / cash flow
H1 / 07 – BALANCE SHEET / CASH FLOW • Equity ratio at 33% (30.5% year end 06) • Working Capital development as expected, seasonality driven by product mix and raw material availability of natural products • Significant reduction of interest expense (from € -45m to €-19m) • € 33m Income tax expenses

Slide 10: Q2 / 07 - Overview
Q2 / 07 - OVERVIEW 3.7% 400 300 > Fx adjusted growth of 4.8% (€m) Sales 200 317.9 329.7 > Confirms our outlook 100 0 Q2 / 06 Q2 / 07 12.7% 80 60 > EBITDA + € 7.9m yoy EBITDA 1 (€m) 40 62.4 > EBITDA grows stronger than top line at 70.3 12.7% 20 0 Q2 / 06 Q2 / 07 t > EBITDA margin + 1.7 ppt in Q2 / 07

Slide 11: Sales and margin growth in both divisions and above peers
SALES AND MARGIN GROWTH IN BOTH DIVISIONS AND ABOVE PEERS Recent sales growth outperformance 1 Sales growth by Division 1 H1 / 07 y-o-y sales growth (%) 7.5% 6.1% 6.8 % app. 4.7% F&N S&C Symrise Tier 1 group (average) 2 EBITDA margin development by Division H1 / 07 y-o-y EBITDA margin (%) t 0.5 pp 2

Slide 12: Outlook
OUTLOOK 12

Slide 13: Outlook
OUTLOOK > H1 / 07 figures support our full year target of 5-6% sales growth and >10% EBITDA growth > We expect a strong and growing EBITDA margin above 20% for 2007 > F&N is fully on track, Emerging Markets compensate delays in North America > S&C expects overall robust growth > Promising new busine

Slide 14: Q&A
Q&A Q&A ALWAYS INSPIRING 14 MORE …
Source: Internet Archive copy of investor.symrise.com
More decks from Symrise AG
Q3 2026 Earnings Presentation22 slides · Oct 28, 2026
Investor Presentation (October 2026)39 slides · October 2026
H1 2026 Earnings Presentation25 slides · Jul 30, 2026
Q2 2026 Earnings Presentation29 slides · Jul 30, 2026
Shareholder Meeting (May 2026)19 slides · May 6, 2026
Q1 2026 Earnings Presentation19 slides · Apr 29, 2026